Extensive Frontal Focused Ultrasound-Mediated Blood-Brain Barrier Opening for the Treatment of Alzheimer’s Disease: An Open-Label Prospective Study
The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease.
Distinct patterns of corneal nerve fiber features in secondary parkinsonian patients vs idiopathic Parkinson’s disease
Microstructural integrity of the locus coeruleus and its tracts reflect noradrenergic degeneration in Alzheimer’s and Parkinson’s disease
Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in murine Alzheimer’s disease
Toward a Biomarker Panel measured in CNS-originating Extracellular Vesicles for Improved Differential Diagnosis of Parkinson’s Disease and Multiple System Atrophy
Combined Metabolic Activators Improve Cognitive Functions in Alzheimer’s Disease Patients: A Randomised, Double-Blinded, Placebo-Controlled Phase-II Trial
Enhanced delivery of low-dose of aducanumab via FUS in 5xFAD mice, an AD model
Axonal degeneration in the anterior insular cortex in Parkinson’s disease and Dementia with Lewy bodies: more than just an α-synuclein story